tirzepatide or Who Should Avoid Tirzepatide? Safety Guidelines in Diabetes Treatment Tirzepatide vs. Semaglutide: Best Choice

Frias et al., The Lancet, 2021 (SURPASS-2) Targets Two Key Aging Pathways By activating both GLP-1 and GIP pathways, Tirzepatide offers a more comprehensive approach to reversing metabolic aging compared to single-agonist therapies

Regulation of energy balance by leptin

Notably, the brightness of tumor sites in mice treated with ZFP and ZFPG was significantly reduced compared with the Control group

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

Eligibility still depends on medical review rather than BMI alone

Keep in mind that your tolerance has changed, and the effects arrive faster